Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,148,556
+$731,143 QoQ
Shares Held
9,091
+203.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#1,006
of 2,266 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fi3 FINANCIAL ADVISORS, LLC holds $6,620,183 across 8 Drug Manufacturers - General names. GILD ranks #3 (17.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,501 | $1,905,028 | |
| 2 | ABBV |
AbbVie Inc.
|
7,080 | $1,781,611 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
9,091 | $1,148,556 | |
| 4 | LLY |
ELI LILLY & Co
|
7,465 | $555,769 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,478 | $446,923 | |
| 6 | AMGN |
Amgen Inc
|
1,043 | $377,691 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,064 | $234,167 | |
| 8 | PFE |
Pfizer Inc
|
7,078 | $170,438 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,148,556 | 9,091 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $417,413 | 2,995 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $312,864 | 2,549 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $252,858 | 2,278 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $272,518 | 2,458 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $275,082 | 2,455 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $220,394 | 2,386 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||